Life science

The inner and outer surfaces of the human body are home to thousands of microorganisms including bacteria, fungi and virus, a.k.a. our microbiota. Evidence is growing for the importance of the human microbiota in the clinic, both for numerous common diseases, and as a factor in the inter-individual variation in drug response, digestion of food and regulation of the immune system

As our understanding of the role and composition of the microbiota increases, we begin to appreciate the potential of actively considering and influencing this ‘forgotten organ’ in a health care setting. Large clincial research units and excellence clusters focusing on the microbiome and its potential role in complex disorders is being established and extensivly funded both nationally and internationally. Results emerging from the large efforts are providing insight into both disease pathophysiology of diseases such as inflammatory bowl disease,  sclerotic disorders of liver and bile ducts and metabolic disorders such as diabetes. The potential role of the microbiome as a mediator of disease progression is highlighting the microbiome as a potential taget for intervention.

The microbiota is a complex entity and its role is tightly associated with this complexity. In BIOMCARE we therefore believe it is essential to work with ‘the real deal’ – with samples and methods that capture as much of the complexity as possible. We focus on a sequencing-based solutions to profile the microbiome in a complex sample, and provide custom data processing and statistical analysis to ensure that all information available in these complex datasets is explored and the valuable information extracted and presented for easy usage and further application.